BR9807936A - Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação - Google Patents

Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação

Info

Publication number
BR9807936A
BR9807936A BR9807936-0A BR9807936A BR9807936A BR 9807936 A BR9807936 A BR 9807936A BR 9807936 A BR9807936 A BR 9807936A BR 9807936 A BR9807936 A BR 9807936A
Authority
BR
Brazil
Prior art keywords
preparation
immuno
production
prothrombin complex
tolerant
Prior art date
Application number
BR9807936-0A
Other languages
English (en)
Inventor
Hans-Peter Schwarz
Peter Turecek
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0059497A external-priority patent/AT405608B/de
Priority claimed from AT159297A external-priority patent/AT406824B/de
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of BR9807936A publication Critical patent/BR9807936A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

"PREPARAçãO FARMACêUTICA IMUNO-TOLERANTE DE COMPLEXO DE PRó-TROMBINA, PROCESSO PARA PRODUçãO DE UMA PREPARAçãO, E, UTILIZAçãO DE UMA PREPARAçãO". A invenção refere-se a uma preparação imuno-tolerante de complexo de pró-trombina, a um processo para produção desta preparação, e também à utilização da preparação para a produção de uma droga.
BR9807936-0A 1997-04-08 1998-04-06 Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação BR9807936A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0059497A AT405608B (de) 1997-04-08 1997-04-08 Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
AT159297A AT406824B (de) 1997-09-19 1997-09-19 Immuntolerante prothrombinkomplex-präparation
PCT/AT1998/000091 WO1998044942A1 (de) 1997-04-08 1998-04-06 Immuntolerante prothrombinkomplex-präparation

Publications (1)

Publication Number Publication Date
BR9807936A true BR9807936A (pt) 2000-02-22

Family

ID=25593261

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807936-0A BR9807936A (pt) 1997-04-08 1998-04-06 Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação

Country Status (14)

Country Link
US (1) US6358534B1 (pt)
EP (1) EP0973544B1 (pt)
JP (1) JP3976351B2 (pt)
AT (1) ATE202483T1 (pt)
AU (1) AU737566B2 (pt)
BR (1) BR9807936A (pt)
CA (1) CA2285935C (pt)
DE (1) DE59800935D1 (pt)
DK (1) DK0973544T3 (pt)
ES (1) ES2160410T3 (pt)
NO (1) NO994822L (pt)
PT (1) PT973544E (pt)
SK (1) SK139099A3 (pt)
WO (1) WO1998044942A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA159597A (de) * 1997-09-19 2000-09-15 Immuno Ag Präparat zur behandlung von blutgerinnungsstörungen
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
US20040185534A1 (en) * 2000-10-02 2004-09-23 Knudsen Ida Molgaard Industrial-scale serum-free production of recombinant proteins in mammalian cells
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
DE60137950D1 (de) * 2000-10-02 2009-04-23 Novo Nordisk Healthcare Ag Verfahren zur herstellung vitamin-k-abhängiger proteine
PL368119A1 (en) 2001-10-02 2005-03-21 Novo Nordisk Health Care Ag Method for production of recombinant proteins in eukaryote cells
US6989891B2 (en) 2001-11-08 2006-01-24 Optiscan Biomedical Corporation Device and method for in vitro determination of analyte concentrations within body fluids
RS20050051A (en) * 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Pharmaceutical active ingredient preparation and medicaments that contain thrombin or have a thrombin-generating capacity
WO2004011023A1 (de) * 2002-07-23 2004-02-05 Bio-Products & Bio-Engineering Aktiengesellschaft Thrombingenerierfähige und thrombinhältige pharmazeutische wirkstoffzubereitungen und arzneimittel
US7364562B2 (en) * 2005-10-06 2008-04-29 Optiscan Biomedical Corp. Anti-clotting apparatus and methods for fluid handling system
WO2007120746A2 (en) * 2006-04-11 2007-10-25 Optiscan Biomedical Corporation Anti-clotting apparatus and methods for fluid handling system
WO2008144575A2 (en) 2007-05-18 2008-11-27 Optiscan Biomedical Corporation Fluid injection and safety system
NZ598193A (en) * 2007-12-27 2012-12-21 Baxter Int Chemically Modified Factor IX
EP2652491B1 (en) 2010-12-15 2017-11-29 Baxalta GmbH Eluate collection using conductivity gradient
ES2895173T3 (es) * 2012-06-29 2022-02-17 Emd Millipore Corp Métodos para inactivar virus durante un proceso de purificación de proteínas
IL230150A0 (en) * 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
RU2559576C1 (ru) * 2014-06-09 2015-08-10 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения вирусбезопасного полного протромбинового комплекса
EP3205665A1 (en) * 2016-02-11 2017-08-16 Octapharma AG Method of separating factor viii from blood products

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686385B2 (ja) 1980-01-28 1994-11-02 バクスタ−、インタ−ナショナル、インコ−ポレイテッド 活性プロトロンビン複合体組成物およびその製造方法
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
AT368883B (de) 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
US4412985A (en) 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
US4382083A (en) 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4673733A (en) 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
US5156973A (en) 1988-11-23 1992-10-20 Edward Shanbrom Antiviral blood sampling process and apparatus
JP3145696B2 (ja) 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
IL104530A0 (en) 1992-01-27 1993-05-13 Cryopharm Corp Method of inactivation of viral and bacterial blood contaminants
FI952196A0 (fi) 1995-05-08 1995-05-08 Suomen Punainen Risti Veripalv Framstaellning av immunoglobulin
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
US6686191B1 (en) 1995-09-22 2004-02-03 Bayer Healthcare Llc Preparation of virally inactivated intravenously injectable immune serum globulin

Also Published As

Publication number Publication date
ES2160410T3 (es) 2001-11-01
EP0973544B1 (de) 2001-06-27
WO1998044942A1 (de) 1998-10-15
SK139099A3 (en) 2000-06-12
PT973544E (pt) 2001-12-28
JP2001524953A (ja) 2001-12-04
CA2285935A1 (en) 1998-10-15
NO994822L (no) 1999-12-02
JP3976351B2 (ja) 2007-09-19
AU6812198A (en) 1998-10-30
NO994822D0 (no) 1999-10-04
CA2285935C (en) 2011-01-18
ATE202483T1 (de) 2001-07-15
EP0973544A1 (de) 2000-01-26
US6358534B1 (en) 2002-03-19
DE59800935D1 (en) 2001-08-02
DK0973544T3 (da) 2001-10-15
AU737566B2 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
BR9807936A (pt) Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação
BRPI0318811B8 (pt) derivados de ciclohexanol espirocíclicos
ID26207A (id) ESTRATRIENA TERSUBSTITUSI 11β-HALOGEN-7 αTERSUBSTITUTASI, PROSES UNTUK MEMPRODUKSI SEDIAAN FARMASI YANG MENGANDUNG ESTRATRIENA 11β-HALOGEN-7 αINI DAN JUGA PENGGUNAANNYA UNTUK PRODUKSI ZAT-ZAT FARMASI
ATE315050T2 (de) Verfahren zur herstellung von mehrfach vernetzten hyaluronsäurederivaten
PT915898E (pt) Forma i cristalina de claritromicina
ATE313317T1 (de) Herstellung von therapeutischem mikroschaum
BR0017043A (pt) Imidazo[1,3,5]triazinonas e sua aplicação
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
DE59606920D1 (de) Chirale methylphenyloxazolidinone
DE69920945D1 (de) Verfahren zur herstellung von arzneistoffpartikeln
BR0311940A (pt) Difenilazetidinonas substituìdas no anel, processo para produção das mesmas, medicamentos que contêm esses compostos e uso dos mesmos
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
PT1060175E (pt) Inibidores de triptase
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
RS83104A (en) Process to prepare eplerenone
ATE337796T1 (de) Verfahren zur herstellung von hyperpolarisiertem 129xe
ATE381920T1 (de) Retinolderivate und verfahren zu deren herstellung
ATE325794T1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
HUP9901600A3 (en) Vitamin d analogues, their use, pharmaceutical compositions containing them, process for their production and process producing intermediates
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
MY119688A (en) Use of arylguanidinium xanthogenates as vulcanization accelerators and process for the production thereof

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]